We have isolated a novel gene (GLELO) from Mortierella alpina and its homologue (CEELO 1) from Caenorhabditis elegans and demonstrate the involvement of their encoded proteins in the elongation of C,, polyunsaturated fatty acids.
Introduction
Polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA, 20 : 4n-6), eicosapentaenoic acid (EPA, 20: 511-3) and docosahexaenoic acid (DHA, 22 : 6n-3) are mainly derived from essential fatty acids such as linoleic acid (18:2n-6) and a-linolenic acid (1 8 : 3n-3) by an alternating series of desaturation and elongation reactions [l] . They are important components of human nutrition specifically due to their roles as precursors to eicosanoids, a family of biological effectors involved in inflammatory responses, regulation of blood pressure and reproductive function [2-51. Current sources of AA, EPA and DHA include egg, fish oil and various micro-organisms [6] . None of these sources are economically well-suited for use in human nutrition however. Since plant seed oils are currently the largest source of essential fatty acids in the human diet, modification of the fatty acid biosynthetic pathways by genetic manipulation to produce desired PUFAs in an oilseed crop would provide an economical source of these important fatty acids.
Despite the identification of two key enzymes, A6-and As-desaturases, for PUFA synthesis, the production of transgenic plant oils containing either AA or EPA remains hindered due to the lack of availability of a recombinant enzyme(s) involved in the elongation of PUFAs. In plants and mammals, it is believed that the microsomal fatty acid elongation is a four-step process involving one condensation, two reductions and one dehydration step [7] . To determine the GLA elongation ability of the recombinant yeast clone SC334 (CEELOl), the culture was grown with GLA in selective medium and the product DGLA formed in the lipid fraction was analysed by GC-MS. T h e GC-FAME analysis revealed that the recombinant clone showed a maximum 38% conversion of G L A to DGLA.
Substrate specificity of GLELO-and CEELO I -encoded enzymes
T o determine the substrate specificity of both GLELOp and CEELOlp, we tested the ability of yeast cells expressing either GLELOp or CEELOl p to elongate various substrates, including PUFAs from both n-6 and n-3 pathways (Figure 1 ). Under identical assay conditions, the only substrate other than GLA utilized by GLELOp or CEELOlp was stearidonic acid (STA, 18:4n-3). A 73 yo conversion of S T A to eicosatetranoic acid (20: 4n-3) was acheived in cells expressing GLELOp while 30 yo conversion was observed in the case of CEELOlp. Thus, GLELOp and CEELOp have substrate specificity for C,, PUFAs along both n-6 and n-3 pathways. Thus, we have isolated a cDNA sequence that encodes a PUFA-specific elongation enzyme from M. alpina as well as its homologue from C. elegans.
The same C . elegans CEELOl open reading frame was also identified later by Beaudoin et.al. [16] . It is generally believed that the elongation activity consists of four distinct subunit enzymes, and it is highly unlikely that all four activities are contained within a single polypeptide. Beaudoin et. al. [16] have suggested that the elongation enzyme identified in C. elegans could be a condensing enzyme and that the expression of a single open reading frame might not be expected to result in fatty acid elongation, Therefore, the elongation activity observed with the expression of GLELO or CEELOl in yeast is likely to arise from an interaction with other endogenous components of a yeast elongase, such as reductases and dehydratase. A detailed biochemical characterization is necessary to address this hypothesis. Nonetheless, the availability of a recombinant PUFA elongation enzyme as well as desaturases offers the exciting possibility of modifying the PUFA metabolism in plants.
